859 related articles for article (PubMed ID: 27714465)
21. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
; Jiang XY
Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
[TBL] [Abstract][Full Text] [Related]
22. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
24. IgA Nephropathy in Children: A Multicenter Study in Poland.
Mizerska-Wasiak M; Turczyn A; Such A; Cichoń-Kawa K; Małdyk J; Miklaszewska M; Pietrzyk J; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Szczepańska M; Bieniaś B; Zajączkowska M; Pukajło-Marczyk A; Zwolińska D; Siniewicz-Luzeńczyk K; Tkaczyk M; Gadomska-Prokop K; Grenda R; Demkow U; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2016; 952():75-84. PubMed ID: 27573641
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous remission of nephrotic syndrome in a patient with IgA nephropathy.
Hogg RJ; Savino DA
Pediatr Nephrol; 1990 Jan; 4(1):36-8. PubMed ID: 2206879
[TBL] [Abstract][Full Text] [Related]
26. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
Zhong Z; Tang Y; Tan J; Tan L; Pei G; Qin W
Int Urol Nephrol; 2021 Jan; 53(1):121-127. PubMed ID: 32944888
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
[TBL] [Abstract][Full Text] [Related]
28. Long-term morbidity of IgA nephropathy in children evaluated with newly proposed remission criteria in Japan.
Matsushita S; Ishikura K; Okamoto S; Okuda Y; Nagaoka Y; Harada R; Hamada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Ogata K; Honda M
Clin Exp Nephrol; 2015 Dec; 19(6):1149-56. PubMed ID: 25800961
[TBL] [Abstract][Full Text] [Related]
29. Factors related to recurrence of proteinuria in childhood IgA nephropathy.
Shima Y; Mukaiyama H; Tanaka Y; Shimabukuro W; Nozu K; Kaito H; Tanaka R; Sako M; Iijima K; Tokuhara D; Yoshikawa N; Nakanishi K
Pediatr Nephrol; 2024 Feb; 39(2):463-471. PubMed ID: 37594578
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
[TBL] [Abstract][Full Text] [Related]
32. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
33. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Shima Y; Nakanishi K; Kamei K; Togawa H; Nozu K; Tanaka R; Sasaki S; Iijima K; Yoshikawa N
Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome.
Kim SM; Moon KC; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S44-9. PubMed ID: 19194561
[TBL] [Abstract][Full Text] [Related]
35. Prognostic indicators and treatment of childhood IgA nephropathy.
Hogg RJ
Contrib Nephrol; 1995; 111():194-9; discussion 199-200. PubMed ID: 7758342
[No Abstract] [Full Text] [Related]
36. Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function.
Ogura S; Moriyama T; Miyabe Y; Karasawa K; Nitta K
Clin Exp Nephrol; 2021 Oct; 25(10):1103-1110. PubMed ID: 34101029
[TBL] [Abstract][Full Text] [Related]
37. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
38. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
39. First-year GFR slope and long-term renal outcome in IgA nephropathy.
Lee K; Shin J; Park J; Hwang S; Jang HR; Huh W; Kwon GY; Kim YG; Oh HY; Lee JE; Kim DJ
Eur J Clin Invest; 2018 Jun; 48(6):e12936. PubMed ID: 29660832
[TBL] [Abstract][Full Text] [Related]
40. Severity of nephrotic IgA nephropathy according to the Oxford classification.
Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
